Rockefeller Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.36K Hold
225
﹤0.01% 4387
2025
Q4
$2.59K Sell
225
-340
-60% -$5.25K ﹤0.01% 4255
2025
Q3
$13.7K Buy
+565
New +$9.41K ﹤0.01% 3528
2022
Q3
Sell
-15
Closed -$3K 3915
2022
Q2
$3K Sell
15
-21,164
-100% -$7.09M ﹤0.01% 3622
2022
Q1
$11.6M Buy
21,179
+1,088
+5% +$658K 0.06% 326
2021
Q4
$13.3M Buy
20,091
+668
+3% +$511K 0.06% 297
2021
Q3
$16.3M Buy
19,423
+294
+2% +$298K 0.09% 243
2021
Q2
$24.3M Buy
19,129
+236
+1% +$266K 0.14% 174
2021
Q1
$20.7M Sell
18,893
-27
-0.1% -$35.7K 0.14% 169
2020
Q4
$27M Sell
18,920
-68
-0.4% -$72.5K 0.2% 120
2020
Q3
$13.4M Buy
18,988
+2,434
+15% +$1.77M 0.13% 168
2020
Q2
$11.6M Buy
16,554
+1,372
+9% +$792K 0.12% 169
2020
Q1
$5.31M Buy
+15,182
New +$10.8M 0.07% 215
2019
Q4
Sell
-521
Closed -$175K 2065
2019
Q3
$175K Buy
521
+194
+59% +$62.2K ﹤0.01% 659
2019
Q2
$85K Buy
+327
New +$65.5K ﹤0.01% 722
2018
Q4
Sell
-923
Closed -$231K 904
2018
Q3
$231K Buy
+923
New +$199K ﹤0.01% 334

Other funds holding CDLX

Rockefeller Capital Management's CDLX Position: Q1 2026 in Review

Rockefeller Capital Management held its Cardlytics (CDLX) position steady in Q1 2026 at 225 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #4387.

Rockefeller Capital Management first reported a position in CDLX in Q3 2018 and has held it in 16 quarters since. The position peaked at $27M in Q4 2020. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Rockefeller Capital Management held 225 shares of Cardlytics worth $2.36K as of Q1 2026.
  • Rockefeller Capital Management left its Cardlytics share count unchanged in Q1 2026.
  • Cardlytics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4387 holding.
  • Rockefeller Capital Management first reported a position in Cardlytics in Q3 2018 and has held it in 16 quarters since.
  • Rockefeller Capital Management's Cardlytics position peaked at $27M in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.